Biogen (BIIB) PT Raised to $200 at Wells Fargo
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $209.15 -0.32%
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
28 Buy, 15 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Wells Fargo analyst Mohit Bansal raised the price target on Biogen (NASDAQ: BIIB) to $200.00 (from $190.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Wolfe Research Upgrades Biogen (BIIB) to Outperform
- JD Health International Inc (6618:HK) PT Lowered to HK$60 at Nomura/Instinet
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
